India has now improved cancer care of the highest quality and the tests are proving to be equivalent to the world’s best centers. The government and private companies have developed various models, and with these models, they expect to address the obstacle of providing this service to the entire Indian population in the next decade or so. They claim that it is very necessary to have a dedicated centered factory approach in cancer care to achieve good outcomes, and particularly the need is not only in cities of tier-one but also in cities of tier two and tier three. This can be tackled by using the hub and spoke model for the development of cancer treatment techniques. Data can make a significant difference in the development of new medicines in the age of genomics and drug discovery. When they obtain more data from the Indian population and Asians, they begin to realize that this group of the population has distinct genomics and may, therefore, need different treatment. Genomic data will, therefore, play a major role. Similarly, by using artificial intelligence in imagery or pathology, for example, it is possible to decide what the true diagnosis should be and by using machines we can know whether the individual has certain abnormalities or whether the patient has certain tumors that are more harmful than others. The emphasis is on high-quality care and good results. Now that a very good electronic medical records program has been implemented in India, details can be collected from each patient. This has led to tremendous progress in cancer treatment, along with the advancements in diagnosis of what is considered radiation, chemotherapy, and immunotherapy.